Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,287 hedge funds and large institutions have $51.1B invested in Celgene Corp in 2019 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 358 increasing their positions, 624 reducing their positions, and 168 closing their positions.
1% less capital invested
Capital invested by funds: $51.8B → $51.1B (-$768M)
4% less funds holding in top 10
Funds holding in top 10: 113 → 109 (-4)
7% less funds holding
Funds holding: 1,389 → 1,287 (-102)
43% less repeat investments, than reductions
Existing positions increased: 358 | Existing positions reduced: 624
51% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 168
58% less call options, than puts
Call options by funds: $772M | Put options by funds: $1.83B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$666M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$427M |
| 3 |
Renaissance Technologies
New York
|
+$391M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$372M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$360M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$423M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$413M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$383M |
| 4 |
BG
Baupost Group
Boston,
Massachusetts
|
-$377M |
| 5 |
D.E. Shaw & Co
New York
|
-$349M |
CELG Hedge Fund Activity: Q2 2019 in Review
1,287 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q2 2019, worth a combined $51.1B — down 1.5% from $51.8B a quarter earlier.
Sellers outnumbered buyers: 168 funds closed out of CELG and 83 opened new positions — a net loss of 85 holders — while 624 trimmed existing stakes and 358 added.
The largest buyer was Farallon Capital Management, adding an estimated $666M. The largest seller was Orbis Allan Gray, cutting an estimated $423M.
- 1,287 institutional investors held Celgene Corp (CELG) as of Q2 2019, down from 1,389 in Q1 2019.
- Funds reported $51.1B of Celgene Corp stock for Q2 2019, down 1.5% quarter-over-quarter.
- 83 funds opened new Celgene Corp positions in Q2 2019 and 168 closed out, a net change of -85 holders.
- The largest Celgene Corp buyer in Q2 2019 was Farallon Capital Management, an estimated $666M added.
- The largest Celgene Corp seller in Q2 2019 was Orbis Allan Gray, an estimated $423M sold.
Based on aggregated 13F filings for Q2 2019.